During fetal development, circulating biomarkers can be
measured in maternal or fetal blood to provide information about ongoing
physiological and pathological processes.

A researcher collects multiple fetal biomarkers
throughout gestation. Which pattern of observations would best support the
utility of biomarkers for predicting disease risk?

Question

During fetal development, circulating biomarkers can be
measured in maternal or fetal blood to provide information about ongoing
physiological and pathological processes.

A researcher collects multiple fetal biomarkers
throughout gestation. Which pattern of observations would best support the
utility of biomarkers for predicting disease risk?

Answer

Specific
biomarkers are consistently associated with higher probability of disease in
some fetuses, but not all, indicating risk

Answer

Biomarker
detection allows for effective treatment of the fetus prior to birth

Answer

Absence
of a biomarker means that the corresponding disease will definitely not develop
in the fetus

Answer

The
presence of a biomarker confirms that a disease is present in all fetuses
expressing it, allowing definitive diagnosis

Crowdly

During fetal development, circulating biomarkers can be measured in maternal or...

Want instant access to all verified answers on learning.monash.edu?